Melissa Creary, assistant professor of Health Management and Policy, recently appeared on the television show American Black Journal to discuss sick cell disease. The US Food and Drug Administration recently approved several new gene therapies for the disease.
The Michigan Health Equity Challenge, in partnership with the MolinaCares Accord, recently announced the selection of 10 project finalists. The challenge aims to engage U-M graduate students in developing community-based solutions to health equity challenges in Southeast Michigan.
New research from Maheen Humayun and Zhenhua Yang
Progress toward the elimination of tuberculosis in the United States has been stalled by significant racial and ethnic disparities often masked by state- and national-level data, say University of Michigan researchers.
Q&A with Melissa Creary
Federal approval of a breakthrough gene-editing technology that treats the pain and debilitating effects of sickle cell disease is cause for celebration among a community with few options for relief, but it also comes with concerns that too few people can afford to pay for the therapy.
Michigan Public Health launches new speaker series, The Exchange: Critical Conversations with Michigan Public Health
The University of Michigan Public Health School of Public Health launched the inaugural event of its new speaker series, The Exchange: Critical Conversations with Michigan Public Health, on Nov. 8. The theme of the event, “The Future of Healthy Cities,” aligns with a core topic from the school's research initiative, Public Health IDEAS for Creating Health and Equitable Cities.
The Center for the Assessment of Tobacco Regulations (CAsToR)—a collaboration between the University of Michigan, Georgetown University, and the BC Cancer Research Institute—recently received $20 million in funding to continue its research on the impact of tobacco regulations on tobacco use patterns and their downstream health effects.